JPWO2020200960A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020200960A5
JPWO2020200960A5 JP2021557186A JP2021557186A JPWO2020200960A5 JP WO2020200960 A5 JPWO2020200960 A5 JP WO2020200960A5 JP 2021557186 A JP2021557186 A JP 2021557186A JP 2021557186 A JP2021557186 A JP 2021557186A JP WO2020200960 A5 JPWO2020200960 A5 JP WO2020200960A5
Authority
JP
Japan
Prior art keywords
fragment
variant
lipocalin mutein
subject
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021557186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022526524A5 (https=
JP2022526524A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/058360 external-priority patent/WO2020200960A1/en
Publication of JP2022526524A publication Critical patent/JP2022526524A/ja
Publication of JP2022526524A5 publication Critical patent/JP2022526524A5/ja
Publication of JPWO2020200960A5 publication Critical patent/JPWO2020200960A5/ja
Pending legal-status Critical Current

Links

JP2021557186A 2019-03-29 2020-03-25 喘息の処置のためのリポカリンムテイン Pending JP2022526524A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962826791P 2019-03-29 2019-03-29
US62/826,791 2019-03-29
US201962845774P 2019-05-09 2019-05-09
US62/845,774 2019-05-09
US201962906443P 2019-09-26 2019-09-26
US62/906,443 2019-09-26
PCT/EP2020/058360 WO2020200960A1 (en) 2019-03-29 2020-03-25 Lipocalin mutein for treatment of asthma

Publications (3)

Publication Number Publication Date
JP2022526524A JP2022526524A (ja) 2022-05-25
JP2022526524A5 JP2022526524A5 (https=) 2023-03-29
JPWO2020200960A5 true JPWO2020200960A5 (https=) 2023-03-29

Family

ID=70008540

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021557186A Pending JP2022526524A (ja) 2019-03-29 2020-03-25 喘息の処置のためのリポカリンムテイン

Country Status (11)

Country Link
US (1) US20220193191A1 (https=)
EP (1) EP3946415A1 (https=)
JP (1) JP2022526524A (https=)
KR (1) KR20210146934A (https=)
CN (1) CN113613669A (https=)
AU (1) AU2020252050A1 (https=)
CA (1) CA3133422A1 (https=)
IL (1) IL286756A (https=)
MA (1) MA55490A (https=)
SG (1) SG11202109839YA (https=)
WO (1) WO2020200960A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020253034A1 (en) * 2019-03-29 2021-08-19 Pieris Pharmaceuticals Gmbh Inhaled administration of lipocalin muteins
KR20230121785A (ko) 2020-12-18 2023-08-21 아스트라제네카 에이비이 천식 치료용 리포칼린 뮤테인 건조 분말 제형
WO2023143351A1 (zh) 2022-01-29 2023-08-03 上海盛迪医药有限公司 糖皮质激素的药物偶联物
CN114780621B (zh) * 2022-06-23 2022-10-04 中铁电气化勘测设计研究院有限公司 一种轨道交通接触网缺陷检索方法
WO2025026216A1 (zh) 2023-07-28 2025-02-06 江苏恒瑞医药股份有限公司 一种含有糖皮质激素的抗体药物偶联物的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
DE19926068C1 (de) 1999-06-08 2001-01-11 Arne Skerra Muteine des Bilin-Bindungsproteins
WO2003029462A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
CA2464690A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of apolipoprotein d
WO2005019255A1 (en) 2003-08-25 2005-03-03 Pieris Proteolab Ag Muteins of tear lipocalin
WO2006056464A2 (en) 2004-11-26 2006-06-01 Pieris Ag Compound with affinity for the cytotoxic t lymphocyte-associated antigen (ctla-4)
US8313924B2 (en) 2006-08-01 2012-11-20 Pieris Ag Muteins of tear lipocalin and methods for obtaining the same
RU2569745C2 (ru) * 2010-06-08 2015-11-27 Пиерис АГ Мутеины липокалина слезы, связывающие альфа il-4 r
ES2710384T3 (es) * 2011-12-13 2019-04-24 Pieris Pharmaceuticals Gmbh Procedimientos para la prevención o el tratamiento de determinados trastornos mediante la inhibición de la unión de IL-4 y/o IL-13 a sus respectivos receptores

Similar Documents

Publication Publication Date Title
JP6807409B2 (ja) 高濃度の一酸化窒素の投与法
AU2019319953B2 (en) Use of inhaled nitric oxide (INO) for the improvement of severe hypoxemia
JPH05507944A (ja) 顆粒球コロニー刺激因子の肺内投与
JP2015527364A5 (https=)
JP2025013854A (ja) Ｐｄｅ－５阻害剤と吸入用一酸化窒素との併用薬物療法
WO2021207184A1 (en) USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19
KR20200127158A (ko) 폐고혈압의 치료를 위한 흡입 산화질소의 펄스식 투여
AU2021281427A1 (en) Method for pulsatile delivery of a gaseous drug
EP2825179B1 (en) Methods of administering high concentrations of nitric oxide
JP2023512640A (ja) 吸入一酸化窒素（ｉＮＯ）治療を用いた肺動脈コンプライアンスの改善
CN105792828A (zh) 使用莫米松和奥洛他定的组合治疗过敏性鼻炎
WO2021212183A1 (en) Products of manufacture and methods for treating, ameliorating or preventing microbial infections
WO2006065722A2 (en) Compositions and methods for pulmonary conditions
TWI309985B (https=)
JPWO2020200960A5 (https=)
US6592848B1 (en) Mixtures of oxygen and helium for the treatment of respiratory insufficiency
AU2003292120A1 (en) New synergistic combination comprising roflumilast and formoterol
CA2508692A1 (en) Combination medicament
AU2003288169B2 (en) Synergistic combination comprising roflumilast and (R,R) -formoterol
GB2594480A (en) New treatment
JP2009506029A5 (https=)
RU2766246C1 (ru) Способ лечения и реабилитации больных после острых респираторных вирусных инфекций
AR124436A1 (es) Formulación de polvo seco de muteína de lipocalina para el tratamiento del asma
WO2021225960A2 (en) Beta thymosin peptides for treating viral infections
HK40091740A (zh) 用於治疗、改善或预防微生物感染的制造产品和方法